Clinical Trials
2 trialsNCT03316144 2020-09-30
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Completed
NCT02836834 2019-10-22
Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of an Anti-PD-1 mAb for Patients With Advanced Solid Tumors
Shanghai Junshi Bioscience Co., Ltd.
Phase 1 Unknown